Hartaj Singh

As Managing Director – Biotechnology Analyst at BTIG, Hartaj Singh’s primarily responsible for US Biotechnology names, with a secondary responsibility for lateral Pharmaceutical and ex-US Biotechnology names. Hartaj has a combination of 10+ years in drug development and marketing, coupled with 10+ years of successful investment management expertise. He worked as an analyst at a well-regarded hedge fund with an emphasis on fundamental analysis. He has a love for great science and execution of focused management teams.